Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$8.2M Buy
30,523
+1,746
+6% +$436K 0.33% 44
2023
Q2
$6.39M Sell
28,777
-80
-0.3% -$18.6K 0.3% 60
2023
Q1
$6.98M Buy
28,857
+1,089
+4% +$267K 0.38% 44
2022
Q4
$7.29M Buy
27,768
+3,960
+17% +$1.06M 0.45% 40
2022
Q3
$5.37M Buy
+23,808
New +$5.77M 0.41% 43

Other funds holding AMGN

Advisor Partners II's AMGN Position: Q3 2023 in Review

Advisor Partners II increased its Amgen (AMGN) stake by 6.1% in Q3 2023, buying an estimated $436K and bringing the position to 30,523 shares worth $8.2M. The position accounts for 0.33% of the portfolio, ranked #44.

Advisor Partners II first reported a position in AMGN in Q3 2022 and has held it in 5 quarters since. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.

  • Advisor Partners II held 30,523 shares of Amgen worth $8.2M as of Q3 2023.
  • Advisor Partners II bought 1,746 Amgen shares in Q3 2023, an estimated $436K.
  • Amgen made up 0.33% of Advisor Partners II's portfolio in Q3 2023, its #44 holding.
  • Advisor Partners II first reported a position in Amgen in Q3 2022 and has held it in 5 quarters since.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.